Terminal complement inhibition dampens the inflammation during COVID‐19-Reference-Cited by-同舟云学术

Terminal complement inhibition dampens the inflammation during COVID‐19

Published:2020-06-28 Issue:3 Volume:190 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kulasekararaj Austin G.¹²³^ORCID,Lazana Ioanna¹,Large Joanna¹,Posadas Kristina²,Eagleton Helen⁴,Lord Villajin John²,Zuckerman Mark⁵,Gandhi Shreyans¹²^ORCID,Marsh Judith C. W.¹³

Affiliation:

1. Department of Haematological Medicine King's College Hospital‐NHS Foundation Trust LondonUK

2. NIHR/Wellcome King’s Clinical Research Facility LondonUK

3. King's College London LondonUK

4. Department of Haematology Stoke Mandeville Hospital BuckinghamshireUK

5. South London Specialist Virology Centre King’s College Hospital NHS Foundation Trust London UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16916

Reference9 articles.

1. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

2. Natural History of Paroxysmal Nocturnal Hemoglobinuria

3. Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal Hemoglobinuria

4. Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study

5. Complement as a target in COVID-19?

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate;Journal of Intensive Medicine;2024-10

2. COVID-19 vaccination prevents a more severe course and treatment with complement inhibitors reduce worsening hemolysis during the Omicron pandemic in patients with PNH: a single-center study;Annals of Medicine;2023-12-12

3. Severe hemolytic exacerbations of Chinese PNH patients infected SARS‐CoV‐2 Omicron;Immunity, Inflammation and Disease;2023-08

4. The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria;International Journal of Molecular Sciences;2023-05-27

5. Favipiravir therapy for Covid-19 infection and tacrolimus toxicity in a kidney transplant patient on chronic eculizumab therapy;The National Medical Journal of India;2023-01-03